BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sourris KC, Harcourt BE, Penfold SA, Yap FY, Morley AL, Morgan PE, Davies MJ, Baker ST, Jerums G, Forbes JM. Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy. Exp Diabetes Res 2010;2010:974681. [PMID: 21318189 DOI: 10.1155/2010/974681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhuang A, Forbes JM. Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)? Glycoconj J 2016;33:645-52. [PMID: 27270766 DOI: 10.1007/s10719-016-9693-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
2 Egawa T, Tsuda S, Goto A, Ohno Y, Yokoyama S, Goto K, Hayashi T. Potential involvement of dietary advanced glycation end products in impairment of skeletal muscle growth and muscle contractile function in mice. Br J Nutr 2017;117:21-9. [PMID: 28093090 DOI: 10.1017/S0007114516004591] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
3 Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93:1317-1542. [PMID: 23899566 DOI: 10.1152/physrev.00004.2012] [Cited by in Crossref: 254] [Cited by in F6Publishing: 224] [Article Influence: 31.8] [Reference Citation Analysis]
4 Wang J, Liu H, Xie G, Cai W, Xu J. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments. Mol Med Rep 2020;21:685-94. [PMID: 31974594 DOI: 10.3892/mmr.2019.10872] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Ruelas Cinco EDC, Ruíz Madrigal B, Domínguez Rosales JA, Maldonado González M, De la Cruz Color L, Ramírez Meza SM, Torres Baranda JR, Martínez López E, Hernández Nazará ZH. Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin resistance. Iran J Basic Med Sci 2019;22:623-30. [PMID: 31231489 DOI: 10.22038/ijbms.2019.34571.8206] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Zhuang A, Yap FYT, McCarthy D, Leung C, Sourris KC, Penfold SA, Thallas-Bonke V, Coughlan MT, Schulz BL, Forbes JM. Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion. Sci Rep 2019;9:13664. [PMID: 31541173 DOI: 10.1038/s41598-019-50221-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Leung C, Herath CB, Jia Z, Goodwin M, Mak KY, Watt MJ, Forbes JM, Angus PW. Dietary glycotoxins exacerbate progression of experimental fatty liver disease. J Hepatol. 2014;60:832-838. [PMID: 24316518 DOI: 10.1016/j.jhep.2013.11.033] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
8 Czajka A, Ajaz S, Gnudi L, Parsade CK, Jones P, Reid F, Malik AN. Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy. EBioMedicine 2015;2:499-512. [PMID: 26288815 DOI: 10.1016/j.ebiom.2015.04.002] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 13.2] [Reference Citation Analysis]
9 Lv X, Lv GH, Dai GY, Sun HM, Xu HQ. Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway. Chin J Nat Med 2016;14:844-55. [PMID: 27914528 DOI: 10.1016/S1875-5364(16)30101-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 Fuller KNZ, Valentine RJ, Miranda ER, Kumar P, Prabhakar BS, Haus JM. A single high-fat meal alters human soluble RAGE profiles and PBMC RAGE expression with no effect of prior aerobic exercise. Physiol Rep 2018;6:e13811. [PMID: 30047241 DOI: 10.14814/phy2.13811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]